Clinical Trial Update: A Revised Tafenoquine Dose to Improve Radical Cure for Vivax Malaria [Phase 3]

View source ↗

Summary

A Phase 3 trial is testing a revised dosing regimen of tafenoquine to improve radical cure for vivax malaria; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vivax Malaria

Drugs mentioned

• Arakoda (tafenoquine)

Snippet

Sponsor: Menzies School of Health Research | Conditions: Vivax Malaria | Phase 3 | Status: RECRUITING